Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Multivariable Screening Tool Outperforms PSA Alone in Detecting Clinically Significant Prostate Cancer

A population-based screening analysis found that Stockholm3, a test that combines prostate-specific antigen (PSA) levels with genetic, protein, and clinical data into a risk score, identified more clinically significant prostate cancers while missing fewer cases than standard PSA screening.

June 22, 2026


July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026